Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Circular RNAs and their associations with breast cancer subtypes

Open access
Nair, Asha A., Niu, Nifang, Tang, Xiaojia, Thompson, Kevin J., Wang, Liewei, Kocher, Jean-Pierre, Subramanian, Subbaya, Kalari, Krishna R.·2016·Oncotarget

Abstract

// Asha A. Nair 1 , Nifang Niu 2 , Xiaojia Tang 1 , Kevin J. Thompson 1 , Liewei Wang 3 , Jean-Pierre Kocher 1 , Subbaya Subramanian 4 , Krishna R. Kalari 1 1 Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA 2 Division of Genomic and Molecular Pathology, University of Chicago, Chicago, IL, USA 3 Department of Pharmacology, Mayo Clinic, Rochester, MN, USA 4 Division of Basic and Translational Research, University of Minnesota, Minneapolis, MN, USA Correspondence to: Krishna R. Kalari, email: Kalari.Krishna@mayo.edu Subbaya Subramanian, email: subree@umn.edu Keywords: circular RNA, circ-seq, breast cancer, molecular subtypes, proliferation Received: February 23, 2016 Accepted: October 29, 2016 Published: November 05, 2016 ABSTRACT Circular RNAs (circRNAs) are highly stable forms of non-coding RNAs with diverse biological functions. They are implicated in modulation of gene expression thus affecting various cellular and disease processes. Based on existing bioinformatics approaches, we developed a comprehensive workflow called Circ-Seq to identify and report expressed circRNAs. Circ-Seq also provides informative genomic annotation along circRNA fused junctions thus allowing prioritization of circRNA candidates. We applied Circ-Seq first to RNA-sequence data from breast cancer cell lines and validated one of the large circRNAs identified. Circ-Seq was then applied to a larger cohort of breast cancer samples ( n = 885) provided by The Cancer Genome Atlas (TCGA), including tumors and normal-adjacent tissue samples. Notably, circRNA results reveal that normal-adjacent tissues in estrogen receptor positive (ER+) subtype have relatively higher numbers of circRNAs than tumor samples in TCGA. Similar phenomenon of high circRNA numbers were observed in normal breast-mammary tissues from the Genotype-Tissue Expression (GTEx) project. Finally, we observed that number of circRNAs in normal-adjacent samples of ER+ subtype is inversely correlated to the risk-of-relapse proliferation (ROR-P) score for proliferating genes, suggesting that circRNA frequency may be a marker for cell proliferation in breast cancer. The Circ-Seq workflow will function for both single and multi-threaded compute environments. We believe that Circ-Seq will be a valuable tool to identify circRNAs useful in the diagnosis and treatment of other cancers and complex diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.13134

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 161

Metadata

Authors
Nair, A. A., Niu, N., Tang, X., Thompson, K. J., Wang, L., Kocher, J.-P., Subramanian, S., & Kalari, K. R.
Venue
Oncotarget
Published
2016-11-05
Volume
7
Issue
49
Pages
80967-80979
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2548983066
Cited by
161
References
6
FWCI
11.14
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circular RNAs and their associations with breast cancer subtypes. https://app.cochat.ai/papers/10.18632/oncotarget.13134
The paper
Nair, A. A., Niu, N., Tang, X., Thompson, K. J., Wang, L., Kocher, J.-P., Subramanian, S., & Kalari, K. R. (2016). Circular RNAs and their associations with breast cancer subtypes. Oncotarget. https://doi.org/10.18632/oncotarget.13134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.